Inhibition of antigen-induced arthritis in guinea pigs by a selective LTB4 receptor antagonist LY293111Na

Inflammation Research

Volumn 51, Issue 11, 2002, Pages 541-550

  Kuwabara, K ^a   Jyoyama, H ^a   Fleisch, J H ^b   Hori, Yozo ^a  

^a SHIONOGI AND CO LTD   (Japan)

^b ELI LILLY AND COMPANY   (United States)

Author keywords

Antigen induced arthritis; Leukotriene B4; LY293111Na; Neutrophil infiltration; Prostaglandin E2

Indexed keywords

2 [2 PROPYL 3 [3 [2 ETHYL 4 (4 FLUOROPHENYL) 5 HYDROXYPHENOXY]PROPOXY]PHENOXY]BENZOIC ACID; BOVINE SERUM ALBUMIN; CORTICOSTEROID; DEXAMETHASONE; INDOMETACIN; LEUKOTRIENE B4; LEUKOTRIENE B4 RECEPTOR ANTAGONIST; MYELOPEROXIDASE; NONSTEROID ANTIINFLAMMATORY AGENT; PROSTAGLANDIN E2; PROSTAGLANDIN SYNTHASE INHIBITOR;

ANIMAL MODEL; ARTHRITIS; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; ENZYME ACTIVITY; FEMALE; GUINEA PIG; KNEE; NEUTROPHIL; NONHUMAN; RAT;

ANIMALS; ANTI-INFLAMMATORY AGENTS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ARTHRITIS, EXPERIMENTAL; BENZOIC ACIDS; DEXAMETHASONE; DINOPROSTONE; FEMALE; GUINEA PIGS; INDOMETHACIN; JOINTS; LEUKOTRIENE ANTAGONISTS; LEUKOTRIENE B4; NEUTROPHIL INFILTRATION; PEROXIDASE; RATS; RATS, INBRED LEW; RECEPTORS, LEUKOTRIENE B4; SERUM ALBUMIN, BOVINE;

EID: 0036867941     PISSN: 10233830     EISSN: None     Source Type: Journal    
DOI: 10.1007/PL00012425     Document Type: Article

References (49)

1. Henderson WR. The role of leukotrienes in inflammation. Ann Intern Med 1994; 121: 684-97.
2. Goetzl EJ, Pickett WC. Novel structural determinants of the human neutrophil chemotactic activity of leukotriene B. J Exp Med 1981; 153: 482-7.
3. 4 hydrolase in the pathogenesis of psoriasis. Skin Pharmacol 1997; 10: 169-77.
4. 4 antagonism in a primate model of asthma. J Clin Invest 1996; 97: 381-7.
5. 4 by colonic mucosa in inflammatory bowel disease. Gastroenterology 1984; 86: 453-60.
6. 4 in acute renal ischemic-reperfusion injury. Proc Natl Acad Sci USA 2000; 97: 823-8.
7. 4 in inflammation. Crit Rev Immunol 1990; 10: 1-12.
8. 4, a mediator of inflammation present in synovial fluid in rheumatoid arthritis. Ann Rheum Dis 1983; 42: 677-9.
9. 4 and immunological parameters in rheumatoid synovial fluids. Inflammation 1991; 15: 497-503.
10. 2-like activity in synovial fluid in osteoarthritis. Prostaglandins Leukot Essent Fatty Acids 1990; 39: 253-4.
11. Palmblad J, Gyllenhammar H, Lindgren JA, Malmsten CL. Effects of leukotrienes and f-Met-Leu-Phe on oxidative metabolism of neutrophils and eosinophils. J Immunol 1984; 132: 3041-5.
12. 4 stimulates polymorphonuclear leukocyte adhesion to cultured vascular endothelial cells. J Clin Invest 1984; 74: 1552-5.
13. Jones AK, al-Janabi MA, Solanki K, Sobnack R, Greenwood A, Doyle DV et al. In vivo leukocyte migration in arthritis. Arthritis Rheum 1991; 34: 270-5.
14. Leirisalo-Repo M, Paimela L, Koskimies S, Repo H. Function of polymorphonuclear leukocytes in early rheumatoid arthritis. Inflammation 1993; 17: 427-42.
15. 4 receptor antagonist LY293111: In vitro studies. J Pharmacol Exp Ther 1999; 288: 286-94.
16. 4 receptor antagonist. J Med Chem 1995; 38: 4411-32.
17. 4 receptor antagonist. Biochem Pharmacol 1995; 49: 1683-90
18. 4 receptor antagonist. Br J Clin Pharmacol 1996; 42: 457-64.
19. 4 aerosol in rhesus monkeys. J Pharmacol Exp Ther 1996; 277: 341-9.
20. 4 receptor antagonist LY293111: In vivo pulmonary studies. Naunyn-Schmiederbergs Arch Pharmacol 2000; 361: 397-404.
21. 4 receptor antagonist, LY293111Na, on antigen-induced bronchial hyperresponsiveness and leukocyte infiltration in sensitized guinea pigs. Inflamm Res 2001; 50: 136-41.
22. 4 receptor antagonist, LY293111Na, on leukocyte infiltration and collagen-induced arthritis in mice. Eur J Pharmacol 2000; 402: 275-85.
23. Yamashita N, Nakanishi I, Okada Y. Arthritis induced immunologically with cationic amidated bovine serum albumin in the guinea pig. A morphological and biochemical study on the destruction of articular cartilage. Virchows Arch B Cell Pathol Incl Mol Pathol 1991; 60: 57-66.
24. van den Berg WB. Impact of NSAID and steroids on cartilage destruction in murine antigen induced arthritis. J Rheumatol Suppl 1991; 27: 122-3.
25. Andersson SE, Lexmuller K, Alving K, Ekstrom GM. Periarticular tissue levels of cytokine- and endothelin-1-like immunoreactivity during the course of antigen-induced arthritis in the rat. Inflamm Res 1999; 48: 491-6.
26. Blackham A, Griffiths RJ. The effect of FK506 and cyclosporin A on antigen-induced arthritis. Clin Exp Immunol 1991; 86: 224-8.
27. Tanaka K, Shimotori T, Makino S, Aikawa Y, Inaba T, Yoshida C et al. Pharmacological studies of the new antiinflammatory agent 3-formylamino-7-methyl-sulfonylamino-6-phenoxy-4H-1-benzopyran-4-one. 1st communication: Antiinflammatory, analgesic and other related properties. Arzneim Forsch 1992; 42: 935-44.
28. Griffiths RJ. Characterisation and pharmacological sensitivity of antigen arthritis induced by methylated bovine serum albumin in the rat. Agents Actions 1992; 35: 88-95.
29. Danon D, Goldstein L, Marikovsky Y, Skutelsky E. Use of cationized ferritin as a label of negative charges on cell surfaces. J Ultrastruct Res 1972; 38: 500-10.
30. Bradley PP, Priebat DA, Christensen RD, Rothstein G. Measurement of cutaneous inflammation: Estimation of neutrophil content with an enzyme marker. J Invest Dermatol 1982; 78: 206-9.
31. Boughton-Smith NK, Wallace JL, Whittle BJ. Relationship between arachidonic acid metabolism, myeloperoxidase activity and leukocyte infiltration in a rat model of inflammatory bowel disease. Agents Actions 1988; 25: 115-23.
32. Krawisz JE, Sharon P, Stenson WF. Quantitative assay for acute intestinal inflammation based on myeloperoxidase activity. Assessment of inflammation in rat and hamster models. Gastroenterology 1984; 87: 1344-50.
33. 4 receptor antagonist, LY293111, on allergen induced responses in asthma. Thorax 1996; 51: 1178-84.
34. Jovanovic DV, Fernandes JC, Martel-Pelletier J, Jolicoeur FC, Reboul P, Laufer S et al. In vivo dual inhibition of cyclooxygenase and lipoxygenase by ML-3000 reduces the progression of experimental osteoarthritis: Suppression of collagenase 1 and interleukin-1β synthesis. Arthritis Rheum 2001; 44: 2320-30.
35. 4 synthase activities in human chondrocytes: Transcellular biosynthesis of leukotrienes during granulocyte-chondrocyte interaction. Arthritis Rheum 1998; 41: 1645-51.
36. Ochi T, Goto T. Anti-inflammatory effect of FR140423, a novel selective cyclo-oxygenase-2 inhibitor, in rat adjuvant arthritis without gastrointestinal side effects. J Pharm Pharmacol 2000; 52: 553-60.
37. Santos LL, Morand EF, Hutchinson P, Boyce NW, Holdsworth SR. Anti-neutrophil monoclonal antibody therapy inhibits the development of adjuvant arthritis. Clin Exp Immunol 1997; 107: 248-53.
38. Schrier D, Gilbertsen RB, Lesch M, Fantone J. The role of neutrophils in type II collagen-induced arthritis in rats. Am J Pathol 1984; 117: 26-9.
39. Leech M, Hutchinson P, Holdsworth SR, Morand EF. Endogenous glucocorticoids modulate neutrophil migration and synovial P-selectin but not neutrophil phagocytic or oxidative function in experimental arthritis. Clin Exp Immunol 1998; 112: 383-8.
40. Kakimoto K, Matsukawa A, Yoshinaga M, Nakamura H. Suppressive effect of a neutrophil elastase inhibitor on the development of collagen-induced arthritis. Cell Immunol 1995; 165: 26-32.
41. Wang Y, Rollins SA, Madri JA, Matis LA. Anti-C5 monoclonal antibody therapy prevents collagen-induced arthritis and ameliorates established disease. Proc Natl Acad Sci USA 1995; 92: 8955-9.
42. 4 and complement. Jpn J Pharmacol 1989; 50: 234-8.
43. 4 in cardiac tissue and its role in infarct extension through leucocyte migration. Cardiovasc Res 1988; 22: 142-8.
44. Watanabe M, Sugidachi A, Omata M, Hirasawa N, Mue S, Tsurufuji S et al. Possible role for platelet-activating factor in neutrophil infiltration in allergic inflammation in rats. Int Arch Allergy Appl Immunol 1990; 92: 396-403.
45. Watanabe M, Arakida Y, Tanabe J, Sugidachi A, Hirasawa N, Mue S et al. Pharmacological analysis of neutrophil chemotactic factor production by leucocytes and roles of PAF in allergic inflammation in rats. Br J Pharmacol 1994; 111: 123-30.
46. Kurihara Y, Endo H, Akahoshi T, Kondo H. Up-regulation of prostaglandin E receptor EP2 and EP4 subtypes in rat synovial tissues with adjuvant arthritis. Clin Exp Immunol 2001; 123: 323-30.
47. Szekanecz Z, Halloran MM, Volin MV, Woods JM, Strieter RM, Kenneth Haines G 3rd et al. Temporal expression of inflammatory cytokines and chemokines in rat adjuvant-induced arthritis. Arthritis Rheum 2000; 43: 1266-77.
48. Palmblad K, Erlandsson-Harris H, Tracey KJ, Andersson U. Dynamics of early synovial cytokine expression in rodent collagen-induced arthritis: A therapeutic study using a macrophage-deactivating compound. Am J Pathol 2001; 158: 491-500.
49. Weinblatt ME, Kremer JM, Coblyn JS, Helfgott S, Maier AL, Petrillo G et al. Zileuton, a 5-lipoxygenase inhibitor in rheumatoid arthritis. J Rheumatol 1992; 19: 1537-41.